EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 395 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $52,923 | -79.9% | 29,000 | -81.3% | 0.00% | -90.0% |
| Q1 2024 | $263,163 | -88.2% | 155,000 | +67.3% | 0.01% | -93.2% |
| Q4 2023 | $2,222,769 | +1931.4% | 92,654 | -29.7% | 0.15% | +1725.0% |
| Q3 2023 | $109,423 | -77.4% | 131,800 | +77.3% | 0.01% | -68.0% |
| Q2 2021 | $485,000 | +284.9% | 74,322 | +113.7% | 0.02% | +108.3% |
| Q4 2020 | $126,000 | – | 34,781 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |